Literature DB >> 372503

Simple computer quantitation of spleen-to-liver ratios in the diagnosis of hepatocellular disease.

R Wasnich, G Glober, T Hayashi, T Vicher, F Yeh.   

Abstract

Increased splenic uptake of radiocolloids is a helpful sign in the scintigraphic diagnosis of various hepatocellular diseases, but little attempt has been made to quantify this physiologic phenomenon. We have devised a simple computer method that compares average splenic activity to average right-lobe liver activity. The method is reproducible (r = 0.97) and exhibits little interobserver variation (r = 0.99). One hundred clinically normal subjects were found to have a nearly symmetrical distribution of S/L ratios around a mean of 0.77, with a s.d. of 0.20. Fifteen subjects normal by biopsy were found to have a similar mean spleen-to-liver (S/L) ratio of 0.74. Based upon a normal range of 0.37 to 1.17 (0.77 +/- 2 s.d.), elevated S/L ratios were found in fatty metamorphosis (85%), cirrhosis (67%), and chronic hepatitis (43%). Abnormal S/L ratios in the range from 1.17 to approximately 1.4 were not visually obvious. Overall sensitivity of the S/L ratio in these three diseases is 69%. When combined with the other scintigraphic indications of hepatocellular disease (nonhomogenous colloid uptake, hepatomegaly, splenomegaly, and bone-marrow colloidal uptake), the liver scan was found to have a sensitivity of 93%.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 372503

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Perfused Kupffer cell mass. Correlation with histology and severity of chronic liver disease.

Authors:  J Hoefs; K Chang; F Wang; G Kanel; T Morgan; P Braunstein
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

2.  Significance of antibody to hepatitis B core antigen in a hemodialysis unit.

Authors:  R D Wasnich; R Puapongsakorn; D S Seto
Journal:  West J Med       Date:  1980-04

3.  Assessment of hepatic excretory function in chronic liver disease by hepatobiliary scintigraphy.

Authors:  H Itoh; N Takahashi; R Shimono; T Sugawara; M Kawamura; T Tsuda; M Kataoka; A Iio; K Hamamoto; K Ohshima
Journal:  Ann Nucl Med       Date:  1989-11       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.